Swiss Biotech Parenterals

Name

Swiss Biotech Parenterals

Legal name

Swiss Biotech Parentrals

Website

https://swissbiotechparentral.com

Company type

Private

Founded year

2018

Operating status

Operating

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

Keywords

• Pharmaceutical formulations
• Pharmaceutical manufacturing
• Pharma franchise distribution
• Third-party manufacturing
• Injectable pharmaceuticals

Headquarters

HQ city

Karnal

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Pharmaceutical Product Sales: Sale of proprietary pharmaceutical formulations across four branded divisions: Swiss Biotech Parentrals, Bioswiss Pharma, Ipsen Remedies, Swiss Biolabs, and Swiss Psyco Care. Products span therapeutic areas including anti-infectives, CNS/neuroscience, gastrointestinal, cardiovascular, nutritional supplements, and dermatology. Revenue is generated through franchise, PCD distribution, and third-party manufacturing.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Swiss Biotech Parenterals manufactures and distributes a portfolio of 500+ pharmaceutical formulations across tablets, capsules, liquid orals, injectables, ointments, eye drops, and dry syrups. The company operates through four branded divisions (Swiss Biotech Parenterals, Bioswiss Pharma, Ipsen Remedies, Swiss Biolabs, and Swiss Psyco Care) covering eight therapeutic specialities, and offers franchise/PCD distribution as well as third-party contract manufacturing services across India and 15+ export countries.

Product overview

Swiss Biotech Parentrals is a PCD (Propaganda Cum Distribution) pharma franchise company operating through four distinct divisions: Swiss Biotech Parentrals (main brand), Bioswiss Pharma (broad-spectrum pharmaceutical drugs), Ipsen Remedies (oncology, rare disease, and neuroscience medicines), Swiss Biolabs (bio lab/wellness products), and Swiss Psyco Care (psychiatric medications). The company manufactures over 100 products across six dosage forms including tablets, capsules, liquid orals, dry syrups, injectables, ointments, and eye drops, organized into eight therapeutic specialities. They serve franchise and third-party manufacturing customers across 15+ countries worldwide.

Differentiator

Problem solved

Functional benefit

Brands

• Swiss Biolabs: Bio lab products for healthy-lifestyle system.
• Bioswiss Pharma
• Ipsen Remedies
• Swiss Psyco Care

Products and services

• Swiss Biotech Parenterals (main branded division) Primary pharmaceutical brand offering a comprehensive range of tablets, capsules, liquid orals, injectables, ointments, eye drops, and dry syrups across multiple therapeutic segments. Distributed through franchise and PCD partners.
• Bioswiss Pharma Discovers, develops, produces, and markets pharmaceutical drugs for use as medications, covering broad-spectrum therapeutic categories including antibiotics, cardiovascular, and gastrointestinal products.
• Ipsen Remedies Focused on transformative medicines in oncology, rare disease, and neuroscience therapeutic areas, offering specialised pharmaceutical formulations.
• Swiss Biolabs Bio lab products for healthy lifestyle, offering nutraceuticals and wellness-oriented pharmaceutical formulations including tablets, capsules, liquids, and injectables.
• Swiss Psyco Care Psychiatric and neuroscience product line launched after extensive research, covering psychiatric medications, anticonvulsants, and neuropsychiatric formulations.
• Pharmaceutical Franchise & PCD Distribution Program Recruits franchise and PCD (Propaganda-cum-Distribution) partners who distribute Swiss Biotech Parenterals' 500+ pharmaceutical products across India and 15+ countries. Partners receive dedicated relationship management and quality promotional inputs.
• Third-Party / Contract Manufacturing Service Manufactures pharmaceutical formulations for other brands on a third-party/contract basis, covering tablet sections (Beta Lactam and Non-Betalactam) and injectable products.

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators5 records

Recent moves4 records

Expansion highlights5 records

Direct peers

• Macleods Pharmaceuticals: Indian generic pharmaceutical manufacturer offering a broad portfolio across multiple therapeutic areas and dosage forms, with a franchise/PCD distribution presence in domestic and emerging markets — closely comparable to Swiss Biotech Parentrals in business model and product breadth.
• Ipca Laboratories: Indian generic pharmaceutical manufacturer with diverse dosage-form capabilities (tablets, injectables, orals) and both domestic and export channels — direct operational parallel.
• Unichem Laboratories: Indian generic pharmaceutical manufacturer producing formulations across multiple therapeutic categories with branded and institutional sales — similar product breadth and channel structure.
• FDC Limited: Indian pharmaceutical manufacturer focused on generic formulations across multiple therapeutic areas, with domestic franchise distribution — comparable in scale, business model, and product diversification.
• Aristo Pharmaceuticals: Indian generic pharma manufacturer with a wide product portfolio across injectables, tablets, and other dosage forms, serving franchise and institutional customers across multiple therapeutic segments.

Broad incumbents

• Cipla: One of India's largest generic pharmaceutical manufacturers with respiratory, anti-infective, and CNS portfolios plus extensive domestic and export distribution — broader incumbent spanning many of the same therapy areas.
• Intas Pharmaceuticals: Large Indian pharmaceutical company with generics, biosimilars, and specialty therapeutics plus domestic franchise distribution — broader scope but overlapping on injectables, generics, and franchise-led growth.
• Alkem Laboratories: Established Indian generic pharma company with branded generics across antibiotics, CNS, and other therapeutic areas plus domestic and international distribution — broader scale but overlapping therapeutic focus.
• Mankind Pharma: Major Indian pharmaceutical company with a strong domestic franchise/PCD distribution network and a broad generic portfolio — comparable franchise-led go-to-market motion at meaningfully larger scale.
• Zydus Lifesciences (Cadila): Major Indian pharmaceutical company with a wide generic formulation portfolio across multiple dosage forms and therapeutic segments, plus domestic and international presence — overlapping therapeutic and channel coverage.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/in/swiss-biotech-03228b236
• Instagraminstagram.com/swiss_biotech_parentrals

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Swiss Biotech Parenterals